SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (28073)2/13/2002 12:47:46 PM
From: jolox  Read Replies (3) | Respond to of 29382
 
Hi Ken;

DFIB now sitting on 100 day MA support of 3.57. This is same area as original ACT. ACT support at low of 2-11-02, at about 3.50. Between this area should be the basement.

Joel



To: Ken W who wrote (28073)2/13/2002 8:01:16 PM
From: Sergio H  Read Replies (1) | Respond to of 29382
 
Ken and Jose Tuvalu, I'm looking at taking a new position in NPRO. FDA approval of their NDA for paclitaxil should come sometime in March.

NRPO has already established a marketing agreement with Abbott Labs and has settled the law suit with Bristol Myers.

Chart looks similar to other small cap biotechs-bouncing off the 200 day MA, but NPRO's success (or failure) is more immediate.

Give me your opinions.

Sergio


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News